GH Research

Recent news

• Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
  Market Newswire · 2026/8/31
• Rating change
  A Quick Look at Today's Ratings for GH Research(GHRS.US), With a Forecast Between $32 to $39
  Market Newswire · 2026/5/15
• Rating change
  Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $32
  Market Newswire · 2026/3/6
• Rating change
  Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)
  TipRanks · 2026/3/7
• Rating change
  RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
  Market Newswire · 2026/5/16
• Rating change
  Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35
  Market Newswire · 2026/5/16
• Rating change
  Wells Fargo Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $44
  Market Newswire · 2026/7/27
• H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
  Market Newswire · 2026/8/10
• Rating change
  Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $39
  Market Newswire · 2026/8/7
• Rating change
  H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $65
  Market Newswire · 2026/5/19
• Rating change
  Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $34
  Market Newswire · 2026/3/10
• Rating change
  Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40
  Market Newswire · 2026/8/7
• Rating change
  H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)
  TipRanks · 2026/4/29
• Rating change
  Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $32
  Market Newswire · 2026/3/6
• CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
  Market Newswire · 2026/8/8
• Rating change
  Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/5/15
• Rating change
  H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $70
  Market Newswire · 2026/4/29
• Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40
  Market Newswire · 2026/8/7
• TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
  Market Newswire · 2026/8/7
• Rating change
  Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $42
  Market Newswire · 2026/3/6

Headlines are aggregated automatically and are not independently verified or edited by our team.